{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:24:25Z","timestamp":1792110265048,"version":"4.4.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title\/>\n                  <jats:p>Leiomyomas remain highly prevalent by midlife, with persistent racial disparities in age at onset and tumor burden. Although they are traditionally expected to regress after menopause, longitudinal data demonstrate variable behavior, with many leiomyomas persisting, some regressing modestly, and a subset continuing to grow. This structured, nonsystematic review of the contemporary literature was conducted using PubMed and Embase, supplemented by guideline and reference review, with the objective of guiding the evaluation and management of uterine leiomyomas across the menopausal transition. In perimenopausal and postmenopausal patients, abnormal uterine bleeding and pelvic pain require systematic evaluation to exclude endometrial pathology and alternative causes. Transvaginal ultrasonography with structured assessment provides the foundation for evaluation, and magnetic resonance imaging serves as an adjunct when findings are indeterminate or clinical concern is elevated. No single imaging feature reliably distinguishes benign leiomyoma from leiomyosarcoma, and the prevalence of unsuspected leiomyosarcoma at surgery remains low, increasing with age. Management should be individualized and symptom driven, incorporating patient age, comorbidities, hormonal exposures, imaging findings, and preferences, with expectant management appropriate for asymptomatic patients and intervention reserved for refractory symptoms or diagnostic uncertainty.<\/jats:p>","DOI":"10.1097\/aog.0000000000006339","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:00:22Z","timestamp":1780606822000},"page":"626-634","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Uterine Leiomyomas Across the Menopausal Transition"],"prefix":"10.1097","volume":"148","author":[{"given":"Diana","family":"Encalada-Soto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri Silver","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Laughlin-Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"R1-20261015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in Black and White women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20261015","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1001\/jama.2024.0447","article-title":"Uterine fibroids","volume":"331","author":"Marsh","year":"2024","journal-title":"JAMA"},{"key":"R3-20261015","first-page":"e70656","article-title":"Postmenopausal shrinkage of uterine myomas: a retrospective study of 97 cases monitored annually for 10 years","volume":"16","author":"Oue","year":"2024","journal-title":"Cureus"},{"key":"R4-20261015","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ijgo.70527","article-title":"The epidemiology and pathogenesis of uterine fibroids","volume":"171","author":"Munro","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"R5-20261015","doi-asserted-by":"crossref","first-page":"e1934","DOI":"10.1210\/clinem\/dgae625","article-title":"Diabetes and uterine fibroid diagnosis in midlife: Study of Women's Health Across the Nation (SWAN)","volume":"110","author":"Mitro","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20261015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.mayocp.2018.12.012","article-title":"Evaluation and management of abnormal uterine bleeding","volume":"94","author":"Marnach","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R7-20261015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"R8-20261015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/01.AOG.0000428646.67925.9a","article-title":"Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Committee Opinion No. 557. American College of Obstetricians & Gynecologists","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R10-20261015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/13697137.2017.1358921","article-title":"Abnormal uterine bleeding in perimenopause","volume":"20","author":"Goldstein","year":"2017","journal-title":"Climacteric"},{"key":"R11-20261015","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.jacr.2021.02.003","article-title":"ACR Appropriateness Criteria\u00ae postmenopausal acute pelvic pain","volume":"18","author":"Henrichsen","year":"2021","journal-title":"J Am Coll Radiol"},{"key":"R12-20261015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fertnstert.2024.05.003","article-title":"Clinical signs and diagnosis of fibroids from adolescence to menopause","volume":"122","author":"Mension","year":"2024","journal-title":"Fertil Steril"},{"key":"R13-20261015","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Med"},{"key":"R14-20261015","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.3390\/diagnostics13203230","article-title":"Hyaline and cystic degeneration of uterine leiomyomas: CT and MR imaging with histopathological sample analyses","volume":"13","author":"Sotomayor","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R15-20261015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12905-022-01924-6","article-title":"Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma","volume":"22","author":"Tanioka","year":"2022","journal-title":"BMC Womens Health"},{"key":"R16-20261015","first-page":"397","article-title":"Acute pelvic pain: evaluation of 503 cases","volume":"16","author":"Kurt","year":"2013","journal-title":"Arch Iran Med"},{"key":"R17-20261015","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/AOG.0000000000003716","article-title":"Chronic pelvic pain. ACOG Practice Bulletin No. 218. American College of Obstetricians & Gynecologists","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R18-20261015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13669-018-0243-5","article-title":"Natural history of uterine fibroids: a radiological perspective","volume":"7","author":"Ghosh","year":"2018","journal-title":"Curr Obstet Gynecol Rep"},{"key":"R19-20261015","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/humupd\/dmac008","article-title":"Epigenomic and enhancer dysregulation in uterine leiomyomas","volume":"28","author":"Mlodawska","year":"2022","journal-title":"Hum Reprod Update"},{"key":"R20-20261015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","article-title":"A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status","volume":"93","author":"Parsanezhad","year":"2010","journal-title":"Fertil Steril"},{"key":"R21-20261015","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/GME.0000000000001846","article-title":"Growth of surgically confirmed leiomyomas in postmenopausal women: analysis of the influencing factors","volume":"28","author":"Shen","year":"2021","journal-title":"Menopause"},{"key":"R22-20261015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2015-2935","article-title":"Circulating sex hormones and risk of uterine fibroids: Study of Women's Health Across the Nation (SWAN)","volume":"101","author":"Wong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20261015","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/GME.0000000000002043","article-title":"Letter to the Editor re Shen et al","volume":"29","author":"Cohen Rassier","year":"2022","journal-title":"Menopause"},{"key":"R24-20261015","doi-asserted-by":"crossref","first-page":"103955","DOI":"10.1016\/j.critrevonc.2023.103955","article-title":"The biology and treatment of leiomyosarcomas","volume":"184","author":"Kerrison","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"R25-20261015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejogrb.2022.01.013","article-title":"Preoperative clinical characteristics between uterine sarcoma and leiomyoma in patients with uterine mass, a case-control study","volume":"270","author":"Chantasartrassamee","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R26-20261015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/uog.14806","article-title":"Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group","volume":"46","author":"Van den Bosch","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R27-20261015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/uog.24855","article-title":"Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology","volume":"60","author":"Russo","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R28-20261015","doi-asserted-by":"crossref","first-page":"108.e1","DOI":"10.1016\/j.ajog.2024.07.027","article-title":"A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential in patients with myometrial lesions: the MYometrial lesion UltrasouNd and mRi study","volume":"232","author":"Ciccarone","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"R29-20261015","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1007\/s00330-017-5157-5","article-title":"European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas","volume":"28","author":"Kubik-Huch","year":"2018","journal-title":"Eur Radiol"},{"key":"R30-20261015","doi-asserted-by":"crossref","first-page":"e211658","DOI":"10.1148\/radiol.211658","article-title":"MRI evaluation of uterine masses for risk of leiomyosarcoma: a consensus statement","volume":"306","author":"Hindman","year":"2023","journal-title":"Radiology"},{"key":"R31-20261015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5334\/jbsr.2275","article-title":"Diagnostic performance of MRI to differentiate uterine leiomyosarcoma from benign leiomyoma: a meta-analysis","volume":"104","author":"Virarkar","year":"2020","journal-title":"J Belg Soc Radiol"},{"key":"R32-20261015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.fertnstert.2025.12.026","article-title":"Friend or foe after menopause: tamoxifen and uterine fibroid dynamics","volume":"125","author":"Marion","year":"2026","journal-title":"Fertil Steril"},{"key":"R33-20261015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.maturitas.2014.04.011","article-title":"Management of leiomyomas in perimenopausal women","volume":"78","author":"Ciarmela","year":"2014","journal-title":"Maturitas"},{"key":"R34-20261015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/GME.0000000000001438","article-title":"Uterine fibroids in menopause and perimenopause","volume":"27","author":"Ulin","year":"2020","journal-title":"Menopause"},{"key":"R35-20261015","first-page":"CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"Lethaby","year":"2001","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R36-20261015","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/AOG.0000000000002933","article-title":"Elagolix alone or with add-back therapy in women with heavy menstrual bleeding and uterine leiomyomas: a randomized controlled trial","volume":"132","author":"Carr","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R37-20261015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa2008283","article-title":"Treatment of uterine fibroid symptoms with relugolix combination therapy","volume":"384","author":"Al-Hendy","year":"2021","journal-title":"N Engl J Med"},{"key":"R38-20261015","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/AOG.0000000000004291","article-title":"Uterine morcellation for presumed leiomyomas. ACOG Committee Opinion No. 822. American College of Obstetricians & Gynecologists","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R39-20261015","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00404-023-07135-0","article-title":"Myomectomy in adult women of reproductive age: a propensity score-matched study for pregnancy rates","volume":"308","author":"Tinelli","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"R41-20261015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2023.01.022","article-title":"Racial disparities in uterine fibroids and endometriosis: a systematic review and application of social, structural, and political context","volume":"119","author":"Katon","year":"2023","journal-title":"Fertil Steril"},{"key":"R42-20261015","doi-asserted-by":"crossref","first-page":"e255235","DOI":"10.1001\/jamanetworkopen.2025.5235","article-title":"Uterine fibroid diagnosis by race and ethnicity in an integrated health care system","volume":"8","author":"Mitro","year":"2025","journal-title":"JAMA Netw Open"},{"key":"R43-20261015","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jmig.2025.12.024","article-title":"Racial and socioeconomic disparities in approach to treatment of uterine fibroids","volume":"33","author":"Louie","year":"2026","journal-title":"J Minim Invasive Gynecol"},{"key":"R44-20261015","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/jamaoncol.2024.1891","article-title":"Endometrial thickness as diagnostic triage for endometrial cancer among Black individuals","volume":"10","author":"Doll","year":"2024","journal-title":"JAMA Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:01:34Z","timestamp":1792069294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006339","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"2026-03-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}